Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs BLISS GVS PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA BLISS GVS PHARMA LACTOSE INDIA/
BLISS GVS PHARMA
 
P/E (TTM) x 33.4 13.2 253.5% View Chart
P/BV x 4.4 1.4 321.1% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 LACTOSE INDIA   BLISS GVS PHARMA
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-23
BLISS GVS PHARMA
Mar-23
LACTOSE INDIA/
BLISS GVS PHARMA
5-Yr Chart
Click to enlarge
High Rs9691 105.5%   
Low Rs3967 58.3%   
Sales per share (Unadj.) Rs52.372.2 72.4%  
Earnings per share (Unadj.) Rs1.07.4 13.0%  
Cash flow per share (Unadj.) Rs4.79.2 51.1%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs32.284.0 38.3%  
Shares outstanding (eoy) m12.59104.15 12.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.1 118.0%   
Avg P/E ratio x70.610.8 655.8%  
P/CF ratio (eoy) x14.58.7 167.2%  
Price / Book Value ratio x2.10.9 222.9%  
Dividend payout %06.8 0.0%   
Avg Mkt Cap Rs m8548,262 10.3%   
No. of employees `000NANA-   
Total wages/salary Rs m122862 14.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6587,516 8.8%  
Other income Rs m7178 4.1%   
Total revenues Rs m6657,694 8.6%   
Gross profit Rs m1151,173 9.8%  
Depreciation Rs m47187 25.1%   
Interest Rs m60104 58.2%   
Profit before tax Rs m151,061 1.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3293 0.9%   
Profit after tax Rs m12767 1.6%  
Gross profit margin %17.415.6 111.5%  
Effective tax rate %17.527.7 63.1%   
Net profit margin %1.810.2 18.0%  
BALANCE SHEET DATA
Current assets Rs m3756,974 5.4%   
Current liabilities Rs m2661,933 13.7%   
Net working cap to sales %16.667.1 24.8%  
Current ratio x1.43.6 39.1%  
Inventory Days Days4639 117.9%  
Debtors Days Days6931,871 37.0%  
Net fixed assets Rs m6434,562 14.1%   
Share capital Rs m126104 120.9%   
"Free" reserves Rs m2808,646 3.2%   
Net worth Rs m4068,750 4.6%   
Long term debt Rs m330407 81.2%   
Total assets Rs m1,01811,535 8.8%  
Interest coverage x1.211.2 11.1%   
Debt to equity ratio x0.80 1,751.6%  
Sales to assets ratio x0.60.7 99.2%   
Return on assets %7.17.6 94.3%  
Return on equity %3.08.8 34.0%  
Return on capital %10.212.7 80.1%  
Exports to sales %00-   
Imports to sales %31.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m206NA-   
Fx inflow Rs m1045,618 1.8%   
Fx outflow Rs m2091,225 17.0%   
Net fx Rs m-1054,394 -2.4%   
CASH FLOW
From Operations Rs m81343 23.5%  
From Investments Rs m-10-78 13.1%  
From Financial Activity Rs m-84-249 33.6%  
Net Cashflow Rs m-1330 -44.4%  

Share Holding

Indian Promoters % 53.7 35.0 153.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 22.0 2.8%  
FIIs % 0.0 15.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 46.3 65.0 71.3%  
Shareholders   16,088 40,758 39.5%  
Pledged promoter(s) holding % 26.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on LACTOSE INDIA vs BLISS GVS PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LACTOSE INDIA vs BLISS GVS PHARMA Share Price Performance

Period LACTOSE INDIA BLISS GVS PHARMA S&P BSE HEALTHCARE
1-Day -1.34% -0.79% 1.19%
1-Month -1.92% -8.63% -0.74%
1-Year 228.11% 59.10% 61.83%
3-Year CAGR 74.25% 4.08% 18.16%
5-Year CAGR 33.88% -8.65% 19.79%

* Compound Annual Growth Rate

Here are more details on the LACTOSE INDIA share price and the BLISS GVS PHARMA share price.

Moving on to shareholding structures...

The promoters of LACTOSE INDIA hold a 53.7% stake in the company. In case of BLISS GVS PHARMA the stake stands at 35.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LACTOSE INDIA and the shareholding pattern of BLISS GVS PHARMA.

Finally, a word on dividends...

In the most recent financial year, LACTOSE INDIA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BLISS GVS PHARMA paid Rs 0.5, and its dividend payout ratio stood at 6.8%.

You may visit here to review the dividend history of LACTOSE INDIA, and the dividend history of BLISS GVS PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.